Clinical trial
A Prospective, Multi-center, Single Arm, Observational, Post-market Clinical Follow-up Study on the Use of the directSTIM™ Deep Brain Stimulation System to Treat Essential Tremor
NCT05795218 is registered in ClinicalTrials.gov with Aleva Neurotherapeutics SA as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multi-center, Single Arm, Observational, Post-market Clinical Follow-up Study on the Use of the directSTIM™ Deep Brain Stimulation System to Treat Essential Tremor
- Lead sponsor
- Aleva Neurotherapeutics SA
- Phase
- Observational
- Overall status
- Terminated
- Start date
- June 21, 2021
- Completion date
- August 8, 2024
- Enrollment
- 21 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.